http://orcid.org/0000-0002-4342-5370
Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Paula Morales & Nadine Jagerovic. (2020) Novel approaches and current challenges with targeting the endocannabinoid system. Expert Opinion on Drug Discovery 15:8, pages 917-930.
Read now
Read now
Chris S. Breivogel, John M. McPartland & Bhavita Parekh. (2018) Investigation of non-CB1, non-CB2 WIN55212-2-sensitive G-protein-coupled receptors in the brains of mammals, birds, and amphibians. Journal of Receptors and Signal Transduction 38:4, pages 316-326.
Read now
Read now
Articles from other publishers (33)
Yiming Bo, Xin Zhao & Liliang Li. (2024) Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors. Clinical Science 138:6, pages 413-434.
Crossref
Crossref
Geng Chen, Nico Staffen, Zhangsong Wu, Xinyu Xu, Jinheng Pan, Asuka Inoue, Tingyi Shi, Peter Gmeiner, Yang Du & Jun Xu. (2024) Structural and functional characterization of the endogenous agonist for orphan receptor GPR3. Cell Research 34:3, pages 262-265.
Crossref
Crossref
Merlin Bresinsky, Aida Shahraki, Peter Kolb, Steffen Pockes & Hannes Schihada. (2023) Development of Fluorescent AF64394 Analogues Enables Real-Time Binding Studies for the Orphan Class A GPCR GPR3. Journal of Medicinal Chemistry 66:21, pages 15025-15041.
Crossref
Crossref
Kiran Thakur, Heena Khan, Amarjot Kaur Grewal & Thakur Gurjeet Singh. (2023) Nuclear orphan receptors: A novel therapeutic agent in neuroinflammation. International Immunopharmacology 124, pages 110845.
Crossref
Crossref
Yingying Nie, Zeming Qiu, Sijia Chen, Zhao Chen, Xiaocui Song, Yan Ma, Niu Huang, Jason G. Cyster & Sanduo Zheng. (2023) Specific binding of GPR174 by endogenous lysophosphatidylserine leads to high constitutive Gs signaling. Nature Communications 14:1.
Crossref
Crossref
Karla Aidee Aguayo-Cerón, Fausto Sánchez-Muñoz, Rocío Alejandra Gutierrez-Rojas, Lourdes Nallely Acevedo-Villavicencio, Aurora Vanessa Flores-Zarate, Fengyang Huang, Abraham Giacoman-Martinez, Santiago Villafaña & Rodrigo Romero-Nava. (2023) Glycine: The Smallest Anti-Inflammatory Micronutrient. International Journal of Molecular Sciences 24:14, pages 11236.
Crossref
Crossref
Maria P. Magariños, Anna Gaulton, Eloy Félix, Tevfik Kiziloren, Ricardo Arcila, Tudor I. Oprea & Andrew R. Leach. (2023) Illuminating the druggable genome through patent bioactivity data. PeerJ 11, pages e15153.
Crossref
Crossref
Jorge Castillo-Arellano, Ana Canseco-Alba, Stephen J. Cutler & Francisco León. (2023) The Polypharmacological Effects of Cannabidiol. Molecules 28:7, pages 3271.
Crossref
Crossref
Oksana Yu. Kytikova, Yulia K. Denisenko, Tatyana P. Novgorodtseva & Ivan S. Kovalenko. (2023) Cannabinoids And Cannabinoid-Like Compounds: Biochemical Characterization And Pharmacological Perspectives. Russian Open Medical Journal 12:1.
Crossref
Crossref
Rocío Alejandra Gutiérrez-Rojas, Karla Aidee Aguayo-Cerón, Cruz Vargas-De-León, Sandra Edith Cabrera-Becerra, Julio Cesar Almanza-Pérez, Fengyang Huang, Santiago Villafaña & Rodrigo Romero-Nava. (2022) Glycine Effect on the Expression Profile of Orphan Receptors GPR21, GPR26, GPR39, GPR82 and GPR6 in a Model of Inflammation in 3T3-L1 Cells. Life 12:11, pages 1687.
Crossref
Crossref
Marziyeh Choupani, Afshar Alihosseini, Majid Monajjemi & Hossein Sakhaeinia. (2022) Theoretical Study of Adsorption of Genistein on Graphene and Graphene Doped with Metal Atoms (Ni, Ti, Cr, Se). journal of ilam university of medical sciences 30:4, pages 94-105.
Crossref
Crossref
Giorgia Galiazzo, Margherita De Silva, Fiorella Giancola, Riccardo Rinnovati, Angelo Peli & Roberto Chiocchetti. (2021) Cellular distribution of cannabinoid‐related receptors TRPV1, PPAR‐gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia. Equine Veterinary Journal 54:4, pages 788-798.
Crossref
Crossref
Raj Kamal Srivastava, Beat Lutz & Inigo Ruiz de Azua. (2022) The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism. Frontiers in Cellular Neuroscience 16.
Crossref
Crossref
David H. Margolin, Nicola L. Brice, Antonia M. Davidson, Kim L. Matthews & Mark B. L. Carlton. (2022) A Phase I, First-in-Human, Healthy Volunteer Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN424, a Novel G Protein-Coupled Receptor 6 Inverse Agonist for Parkinson’s Disease. Journal of Pharmacology and Experimental Therapeutics 381:1, pages 33-41.
Crossref
Crossref
Szymon Hryhorowicz, Marta Kaczmarek-Ryś, Aleksandra Zielińska, Rodney J. Scott, Ryszard Słomski & Andrzej Pławski. (2021) Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review. Frontiers in Immunology 12.
Crossref
Crossref
Anthony Murkar, Joseph De Koninck & Zul Merali. (2021) Cannabinoids: Revealing their complexity and role in central networks of fear and anxiety. Neuroscience & Biobehavioral Reviews 131, pages 30-46.
Crossref
Crossref
Hannes Schihada, Rawan Shekhani & Gunnar Schulte. (2021) Quantitative assessment of constitutive G protein–coupled receptor activity with BRET-based G protein biosensors. Science Signaling 14:699.
Crossref
Crossref
Huikai Sun, Holger Monenschein, Hans H. Schiffer, Holly A. Reichard, Shota Kikuchi, Maria Hopkins, Todd K. Macklin, Stephen Hitchcock, Mark Adams, Jason Green, Jason Brown, Sean T. Murphy, Nidhi Kaushal, Deanna R. Collia, Steve Moore, William J. Ray, Nicole Marion English, Mark Beresford Lewis CarltonNicola L. Brice. (2021) First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson’s Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate. Journal of Medicinal Chemistry 64:14, pages 9875-9890.
Crossref
Crossref
Olivia Sveidahl Johansen, Tao Ma, Jakob Bondo Hansen, Lasse Kruse Markussen, Renate Schreiber, Laia Reverte-Salisa, Hua Dong, Dan Ploug Christensen, Wenfei Sun, Thorsten Gnad, Iuliia Karavaeva, Thomas Svava Nielsen, Sander Kooijman, Cheryl Cero, Oksana Dmytriyeva, Yachen Shen, Maria Razzoli, Shannon L. O’Brien, Eline N. Kuipers, Carsten Haagen Nielsen, William Orchard, Nienke Willemsen, Naja Zenius Jespersen, Morten Lundh, Elahu Gosney Sustarsic, Cecilie Mørch Hallgren, Mikkel Frost, Seth McGonigle, Marie Sophie Isidor, Christa Broholm, Oluf Pedersen, Jacob Bo Hansen, Niels Grarup, Torben Hansen, Andreas Kjær, James G. Granneman, M. Madan Babu, Davide Calebiro, Søren Nielsen, Mikael Rydén, Raymond Soccio, Patrick C.N. Rensen, Jonas Thue Treebak, Thue Walter Schwartz, Brice Emanuelli, Alessandro Bartolomucci, Alexander Pfeifer, Rudolf Zechner, Camilla Scheele, Susanne Mandrup & Zachary Gerhart-Hines. (2021) Lipolysis drives expression of the constitutively active receptor GPR3 to induce adipose thermogenesis. Cell 184:13, pages 3502-3518.e33.
Crossref
Crossref
Jun Wu, Nu Chen, Yongqing Liu, Grzegorz Godlewski, Henry J. Kaplan, Sarah H. Shrader, Zhao-Hui Song & Hui Shao. (2021) Studies of involvement of G-protein coupled receptor-3 in cannabidiol effects on inflammatory responses of mouse primary astrocytes and microglia. PLOS ONE 16:5, pages e0251677.
Crossref
Crossref
Zejiao Li, Biying Jiang, Baolong Cao, Zheng Zhang, Jiannan Zhang, Juan Li, Yan Huang & Yajun Wang. (2021) Characterization of Four Orphan Receptors (GPR3, GPR6, GPR12 and GPR12L) in Chickens and Ducks and Regulation of GPR12 Expression in Ovarian Granulosa Cells by Progesterone. Genes 12:4, pages 489.
Crossref
Crossref
Paula Morales & Nadine Jagerovic. 2021. Cannabinoids and Sleep. Cannabinoids and Sleep
11
25
.
Catalina Pérez-Olives, Rafael Rivas-Santisteban, Jaume Lillo, Gemma Navarro & Rafael Franco. 2021. Cannabinoids and Neuropsychiatric Disorders. Cannabinoids and Neuropsychiatric Disorders
81
92
.
Chanté Muller & Patricia H. Reggio. (2020) An Analysis of the Putative CBD Binding Site in the Ionotropic Cannabinoid Receptors. Frontiers in Cellular Neuroscience 14.
Crossref
Crossref
Kuangfu Hsiao, Chelsea Noble, Wendy Pitman, Nakul Yadav, Suraj Kumar, Gregory R. Keele, Andrea Terceros, Matt Kanke, Tara Conniff, Christopher Cheleuitte-Nieves, Ravi Tolwani, Praveen Sethupathy & Priyamvada Rajasethupathy. (2020) A Thalamic Orphan Receptor Drives Variability in Short-Term Memory. Cell 183:2, pages 522-536.e19.
Crossref
Crossref
Rafael Franco, Rafael Rivas-Santisteban, Irene Reyes-Resina, Mireia Casanovas, Catalina Pérez-Olives, Carlos Ferreiro-Vera, Gemma Navarro, Verónica Sánchez de Medina & Xavier Nadal. (2020) Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids. Pharmacological Research 158, pages 104801.
Crossref
Crossref
Gonzalo Allende, Jesús Chávez-Reyes, Raquel Guerrero-Alba, Priscila Vázquez-León & Bruno A. Marichal-Cancino. (2020) Advances in Neurobiology and Pharmacology of GPR12. Frontiers in Pharmacology 11.
Crossref
Crossref
Israa H. Isawi, Paula Morales, Noori Sotudeh, Dow P. Hurst, Diane L. Lynch & Patricia H. Reggio. (2020) GPR6 Structural Insights: Homology Model Construction and Docking Studies. Molecules 25:3, pages 725.
Crossref
Crossref
Oxana Yu. Kytikova, Juliy M. Perelman, Tatyana P. Novgorodtseva, Yulia K. Denisenko, Viktor P. Kolosov, Marina V. Antonyuk & Tatyana A. Gvozdenko. (2020) Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma. PPAR Research 2020, pages 1-18.
Crossref
Crossref
Riley T. Paulsen & Brian D. Burrell. (2019) Comparative studies of endocannabinoid modulation of pain. Philosophical Transactions of the Royal Society B: Biological Sciences 374:1785, pages 20190279.
Crossref
Crossref
Oksana Y. Kytikovа, Tatyana P. Novgorodtseva, Yuliya K. Denisenko, Marina V. Antonyuk & Tatyana A. Gvozdenko. (2019) The Role of the Endocannabinoid Signaling System in the Pathophysiology of Asthma and Obesity. Annals of the Russian academy of medical sciences 74:3, pages 200-209.
Crossref
Crossref
Chanté Muller, Paula Morales & Patricia H. Reggio. (2019) Cannabinoid Ligands Targeting TRP Channels. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Fernanda F. Peres, Alvaro C. Lima, Jaime E. C. Hallak, José A. Crippa, Regina H. Silva & Vanessa C. Abílio. (2018) Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?. Frontiers in Pharmacology 9.
Crossref
Crossref